Psychology, Department of

 

Document Type

Article

Date of this Version

4-28-2005

Citation

United States Patent Application Publication Pub. No.: US 2005/0089524A1

Abstract

Compounds are disclosed comprising molecular adjuvants having an antigen presenting cell-targeting ligand linked to a nicotine hapten. Methods are disclosed for employing the compounds as a nicotine vaccine for treatment or prevention of nicotine addiction.

Included in

Psychology Commons

Share

COinS